Pharmacological treatment of cardiovascular risk factors in patients with psoriasis: A Danish nationwide study

J Eur Acad Dermatol Venereol. 2023 May;37(5):e608-e610. doi: 10.1111/jdv.18873. Epub 2023 Jan 27.

Authors

M S Liljendahl^{1

2}, N Loft¹, A Passey³, S Wegner⁴, A Egeberg^{2

5}, L Skov^{1

5}

Affiliations

¹ Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, København, Denmark.
² Department of Dermatology and Venereology, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, København, Denmark.
³ Janssen-Cilag, High Wycombe, UK.
⁴ Janssen-Cilag, Neuss, Germany.
⁵ Department of Clinical Medicine, University of Copenhagen, København, Denmark.

PMID: 36648140
DOI: 10.1111/jdv.18873

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / etiology
Cardiovascular Diseases* / prevention & control
Denmark / epidemiology
Heart Disease Risk Factors
Humans
Psoriasis* / complications
Psoriasis* / drug therapy
Risk Factors

Grants and funding

Janssen Pharmaceuticals